These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 15220246

  • 1. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes.
    Schulze MB, Rimm EB, Shai I, Rifai N, Hu FB.
    Diabetes Care; 2004 Jul; 27(7):1680-7. PubMed ID: 15220246
    [Abstract] [Full Text] [Related]

  • 2. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes.
    Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB.
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4542-8. PubMed ID: 15914524
    [Abstract] [Full Text] [Related]

  • 3. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians.
    Nayak BS, Ramsingh D, Gooding S, Legall G, Bissram S, Mohammed A, Raychaudhuri A, Sahadeo B, Pandohie V, Figaro K.
    Prim Care Diabetes; 2010 Oct; 4(3):187-92. PubMed ID: 20580627
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients.
    Ahmad Khan H.
    Acta Diabetol; 2007 Dec; 44(4):193-200. PubMed ID: 17786383
    [Abstract] [Full Text] [Related]

  • 5. Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study.
    Klüppelholz B, Thorand B, Koenig W, de Las Heras Gala T, Meisinger C, Huth C, Giani G, Franks PW, Roden M, Rathmann W, Peters A, Herder C.
    Diabetologia; 2015 Oct; 58(10):2269-77. PubMed ID: 26155746
    [Abstract] [Full Text] [Related]

  • 6. Adiponectin and future coronary heart disease events among men with type 2 diabetes.
    Schulze MB, Shai I, Rimm EB, Li T, Rifai N, Hu FB.
    Diabetes; 2005 Feb; 54(2):534-9. PubMed ID: 15677512
    [Abstract] [Full Text] [Related]

  • 7. Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects.
    Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA, Campbell LV.
    Diabetes Care; 2004 Aug; 27(8):2033-40. PubMed ID: 15277436
    [Abstract] [Full Text] [Related]

  • 8. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.
    Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM.
    Diabetes; 2002 Oct; 51(10):2968-74. PubMed ID: 12351435
    [Abstract] [Full Text] [Related]

  • 9. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin.
    Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimbürger O, Zhang Z, Hoff C, Holmes C, Axelsson J, Arvidsson S, Schalling M, Barany P, Lindholm B, Nordfors L.
    Kidney Int; 2004 Jan; 65(1):274-81. PubMed ID: 14675060
    [Abstract] [Full Text] [Related]

  • 10. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.
    Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS.
    Diabetes Care; 2003 Jun; 26(6):1745-51. PubMed ID: 12766104
    [Abstract] [Full Text] [Related]

  • 11. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.
    Pellmé F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, Wiklund O, Taskinen MR, Jansson PA.
    Diabetes; 2003 May; 52(5):1182-6. PubMed ID: 12716750
    [Abstract] [Full Text] [Related]

  • 12. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?
    Gungor N, Bacha F, Saad R, Janosky J, Arslanian S.
    Diabetes Care; 2005 Mar; 28(3):638-44. PubMed ID: 15735201
    [Abstract] [Full Text] [Related]

  • 13. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [Abstract] [Full Text] [Related]

  • 14. Subclinical Inflammation and Endothelial Dysfunction in Young Patients with Diabetes: A Study from United Arab Emirates.
    Aburawi EH, AlKaabi J, Zoubeidi T, Shehab A, Lessan N, Al Essa A, Yasin J, Saadi H, Souid AK.
    PLoS One; 2016 Feb; 11(7):e0159808. PubMed ID: 27459718
    [Abstract] [Full Text] [Related]

  • 15. Relationship between adiponectin, glycemic control and blood lipids in diabetic type 2 postmenopausal women with and without complication of ischemic heart disease.
    Jaleel F, Jaleel A, Aftab J, Rahman MA.
    Clin Chim Acta; 2006 Aug; 370(1-2):76-81. PubMed ID: 16516182
    [Abstract] [Full Text] [Related]

  • 16. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance.
    von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, Hamann A, Morcos M, Kreuzer J, Bierhaus A, Nawroth PP, Dugi KA.
    Diabetes Care; 2004 Dec; 27(12):2925-9. PubMed ID: 15562208
    [Abstract] [Full Text] [Related]

  • 17. Plasma adiponectin and insulin resistance in Korean type 2 diabetes mellitus.
    Kim MJ, Yoo KH, Park HS, Chung SM, Jin CJ, Lee Y, Shin YG, Chung CH.
    Yonsei Med J; 2005 Feb 28; 46(1):42-50. PubMed ID: 15744804
    [Abstract] [Full Text] [Related]

  • 18. Relationship of serum adiponectin with blood lipids, HbA(1)c, and hs-CRP in type II diabetic postmenopausal women.
    Goodarzi MT, Babaahmadi-Rezaei H, Kadkhodaei-Eliaderani M, Haddadinezhad S.
    J Clin Lab Anal; 2007 Feb 28; 21(3):197-200. PubMed ID: 17506484
    [Abstract] [Full Text] [Related]

  • 19. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo.
    Schneider JG, von Eynatten M, Schiekofer S, Nawroth PP, Dugi KA.
    Diabetes Care; 2005 Sep 28; 28(9):2181-6. PubMed ID: 16123487
    [Abstract] [Full Text] [Related]

  • 20. A selective peroxisome proliferator-activated receptor alpha agonist, CP-900691, improves plasma lipids, lipoproteins, and glycemic control in diabetic monkeys.
    Wagner JD, Shadoan MK, Zhang L, Ward GM, Royer LJ, Kavanagh K, Francone OL, Auerbach BJ, Harwood HJ.
    J Pharmacol Exp Ther; 2010 Jun 28; 333(3):844-53. PubMed ID: 20190014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.